Phase I study of concomitant chemoradiation with raltitrexed in locally advanced head and neck cancer

European Journal of Cancer

Volumn 41, Issue 1, 2005, Pages 93-97

  Planting, A ^a   De Jonge, M ^a   Jansen, P ^a   Kerrebijn, J ^a   Smith, M ^b   Verweij, J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Astra Zeneca   (Netherlands)

Author keywords

Head and neck cancer; Phase 1 study; Radiotherapy; Raltitrexed

Indexed keywords

ANTINEOPLASTIC AGENT; RALTITREXED; THYMIDYLATE SYNTHASE INHIBITOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; LUNG ABSCESS; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NEPHROTOXICITY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; QUINAZOLINES; RADIOTHERAPY; THIOPHENES;

EID: 11144294825     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.09.022     Document Type: Article

References (18)

1. E. Vokes, D.J. Haraf, and M.S. Kies The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer Semin Oncol 27 suppl 8 2000 34 38
2. E. Van Cutsem, D. Cunningham, J. Maroun, A. Cervantes, and B. Glimelius Raltitrexed: current clinical status and future directions Ann Oncol 13 2002 513 522
3. V. Valentini, G.B. Doglietto, and A.G. Morganti Preoperative chemoradiation with raltitrexed (Tomudex) for T2/N+ and T3/N+ rectal cancers: a phase I study Eur J Cancer 37 2001 2050 2055
4. N. Botwood, R. James, C. Vernon, and P. Price Raltitrexed (tomudex) and radiotherapy can be combined as postoperative treatment for rectal cancer Ann Oncol 11 2000 1023 1028
5. R.D. James, N. Botwood, C.C. Vernon, and P. Price Raltitrexed plus radiotherapy for the treatment of unresectable/recurrent rectal cancer: a phase I study Ann Oncol 14 2003 570 573
6. B.A. Teicher, G. Ara, Y.N. Chen, A. Rechte, and C.N. Coleman Interaction of tomudex with radiation in vitro and in vivo Int J Oncol 13 1998 437 442
7. J.P. Pignon, J. Bourhis, and C. Domenge Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data Lancet 355 2000 949 955
8. R.B. Tishler, C.M. Norris Jr., and A.D. Colevas A phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck Cancer 95 2002 1472 1481
9. M. Machtay, and D.I. Rosenthal Organ preservation using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial J Clin Oncol 20 2002 3964 3971
10. J.M. Prades, T.M. Schmitt, and A.P. Timoshenko Concomitant chemoradiotherapy in pyriform sinus carcinoma Arch Otolaryngol Head Neck Surg 128 2002 384 388
11. M. Airoldi, L. Cattel, and G. Cortesina Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II study Am J Clin Oncol 27 2004 155 163
12. S.J. Clarke, J. Zalcberg, and I. Olver Open label, multi-center phase II study of raltitrexed (tomudex) in patients with inoperable squamous-cell carcinoma of the head and neck Ann Oncol 11 2000 239 241
13. W.E. Samlowski, D. Lew, and P.J. Kuebler Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study Invest New Drugs 16 1999 271 274
14. M.E. Alden, R.C. O'Reilly, A. Topham, L. Dale Lowry, H. Brodovsky, and W.J. Curran Jr. Elapsed radiation therapy treatment time as a predictor of survival in patients with advanced head and neck cancer who receive chemotherapy and radiation therapy Radiology 201 1996 675 680
15. J.W. Denham, and R.L. Abbott Concurrent cisplatin, infusional fluorouracil and conventionally fractionated radiation therapy in head and neck cancer: dose-limiting mucosal toxicity J Clin Oncol 9 1991 458 463
16. L. Tomio, P.L. Zorat, and A. Paccagnella A pilot study of concomitant radiation and chemotherapy in patients with locally advanced head and neck cancer Am J Clin Oncol 16 1993 264 267
17. P. Wibault, and M. Bensmaïne Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7- week continuous infusional fluorouracil J Clin Oncol 14 1996 1192 1200
18. D. Rischin, L. Peters, and R. Hicks Phase I trial of concurrent tirapamazine, cisplatin and radiotherapy in patients with advanced head and neck cancer J Clin Oncol 19 2001 535 542